AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

BICARBONATE DE SODIUM

9 registrations across 3 African markets— 8 active

Markets with BICARBONATE DE SODIUM

Recent registrations

Brand / ProductMarketHolderStatusExpires
BICARBONATE MONOSODIQUE
Solution injectable pour perfusion / 1.4%
🇹🇳TunisiaSIPHATexpiredJun 2000
BICARBONATE DE SODIUM COOPER 1,4%
solution pour perfusion / 1,4 %
🇸🇳SenegalCOOPERactive
BICARBONATE DE SODIUM LAPROPHAN
SOLUTION POUR PERFUSION
🇲🇦Moroccoactive
SOLUTION DE BICARBONATE
solution buvable / 45g /100 ml
🇸🇳SenegalBRAUNactive
SODIUM BICARBONATE
ampoule injectable / 140 mg
🇸🇳SenegalRENAUDINactive
BICARBONATE DE SODIUM COOPER 1,4%
solution pour perfusion / 0,14 mg / 10 ml
🇸🇳SenegalCOOPERactive
BICARBONATE DE SODIUM LAPROPHAN
SOLUTION POUR PERFUSION
🇲🇦Moroccoactive
BICARBONATE DE SODIUM COOPER 1,4%
solution pour perfusion / 1,4 %
🇸🇳SenegalCOOPERactive
BICARBONATE DE SODIUM COOPER 1,4%
solution pour perfusion / 0,14 mg / 10 ml
🇸🇳SenegalCOOPERactive

BICARBONATE DE SODIUM in Africa — Regulatory Overview

BICARBONATE DE SODIUM is registered across 3 African markets with 9 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Senegal, Morocco, Tunisia. AfricaRegulatory refreshes this data daily from official government sources.

Of the 9 registrations, 8 (89%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.